Cholangiocarcinoma;Cholangiokarzinome

Internist

Volumn 38, Issue 10, 1997, Pages 970-976

  Schmielau, J ^a   Klempnauer, J ^a   Schmiegel, W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN;

BILE DUCT CARCINOMA; HUMAN; PATHOGENESIS; REVIEW;

EID: 0030929929     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050108     Document Type: Review

References (64)

1. Pitt HA, Dooley WC, Yeo CJ,Cameron JL (1995) Malignancies of the biliary tree. Curr Probl Surg 32:1-90
2. Carriaga MT, Henson DE (1995) Liver, Gallbiadder, extrahepatic bile ducts, and pancreas. Cancer 75:171-190
3. Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170-178
4. Spiessl BO, Beahrs H, Hermanek R Hutter RVP, Scheibe O, Sobin LH, Wagner G,eds. (1992) UICC TNM atlas, illustrated guide to the TNM/pTNM classification of malignant tumours. 3rd ed.Springer.Berlin
5. Chijiiwa K, lchimiya H, Kuroki S, Koga A, Nakayama F (1993) Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol Obstet 177:279-282
6. Haswell-Elkins MR, Satarug S,Elkins DB (1992) Opisthorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma. J Gastroenterol Hepatol 7:538-548
7. Voyles CR, Smadja C, ShandsWC, BIumgart LH (1983) Carcinoma in choledochal cysts: age-related incidence. Arch Surg 118:986-988
8. Rosen CB, Nagorney DM, Wiesner RH, Coffey Jr. RJ, LaRusso NF (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213:21-25
9. Mir-Madjlessi SH, Farmer RG, Sivak Jr. MV (1987) Bile duct carcinoma in patients with ulcerative colitis: relationship to sclerosing cholangitis. Dig Dis Sci 32:145-154
10. Lto Y, Kojiro M, Nakashima T, Mori T (1988) Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, Cholangiocarcinoma, and hepatic angiosarcoma. Cancer 62:1153-1162
11. Ohashi K, Nakajima Y, Kanehiro H,Tsutsumi M, Taki J, Aomatsu Y,Yoshimura A, Ko S, Kin T, Yagura K, Konishi Y, Nakano H (1995) Ki-ras mutations and p53 protein expression in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology 109:1612-1617
12. Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R (1996) p53 Protein overexpression in Cholangiocarcinoma arising in primary sclerosing cholangitis. Gut 38:265-268
13. lnk4B/MTS2 genes in biliary tract cancer. Cancer Res 55:2756-2760
14. Okuda K, Onto M, Tsuchiya Y (1988) The role of ultrasound, percutaneous transhepatic cholangiography, computed tomography, and magnetic resonance imaging in the preoperative assessment of bile duct cancer. World J Surg 12:18-26
15. Robledo R, Muro A, Prieto ML (1996) Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumor. Radiology 198:869-873
16. Tio TL, Cheng J, Wijers OB, Sars PRA, Tytgat GNJ (1991) Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging. Gastroenterology 100:1351-1361
17. Kersting-Sommerhoff B, Helmberger H, Bautz W (1993) Radiologic diagnosis and staging of gallbladder and bile duct cancer. Endoscopy 25:86-91
18. Choi B, Lee J, Ban M, Kim S, Yi J, Kim C (1989) Hilar Cholangiocarcinoma: comparative study with sonography and CT. Radiology 172:689-692
19. Thorsen MK, Quiroz F, Lawson TL, Smith D, Foley W,Stewart E (1984) Primary biliary carcinoma: CT evaluation. Radiology 152:479-483
20. YamashitaY, Takahashi M, Kanazawa S, Charnsangavej C,Wallace S (1992) Parenchymal changes of the liver in Cholangiocarcinoma: CT evaluation. Gastrointest Radiol 17:161-166
21. Tanaka M, Ogawa Y, Matsumoto S, Nakayama F (1988) The role of endoscopic retrograde cholangiopancreaticography in preoperative assessment of bile duct cancer. World J Surgi 2:27-32
22. Ramage JK, Donaghy A, Farrant JM, lorns R, Williams R (1995) Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108:865-869
23. Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, Demetris AJ, Baddour N, Irish W, VanThiel DH, Starzl TE (1993) Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 25:1124-1125
24. Bismuth H, Castaing D, Traynor O (1988) Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surgi 12:39-47
25. Falkson G, Maclntyre J,Moertel C (1984) Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54:965-969
26. Harvey J, Smith F, Schein P (1984) 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 2:1245-1248
27. Taal B, Audisio R, Bleiberg H, Blijham G, Neijt J, Veenhof C, Duez N, Sahmoud T (1993) Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol 4:607-609
28. Okada S, lshii H, Nose H, Yoshimori M, Okusaka T, Aoki K, Iwasaki M, Furuse J,Yoshino M (1994) A phase II study of cisplatin in patients with biliary tract carcinoma. Oncology 51:515-517
29. Takada T, Kato H, Matsushiro T, Nimura Y, Nagakawa T, Nakayama T (1994) Comparison of S-fluorouracil, doxorubicin and mitomycin C with S-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology 51:396-400
30. Kajanti M, Pyrhonen S (1994) Epirubicin-sequentialmethotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 17:223-226
31. WatkinsE,Oberfield R, Cady B, Clouse M (1978) Arterial infusion chemotherapy of diffuse hepatic malignancies. Prog Clin Cancer 7:235-245
32. Reed M, Vaitkevidus V, AI-Sarraf M, Vaughn C, Singhakowinta A, Sexon-Porte M, Izbicki R, Baker L, Straatsma G (1981) The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer 47:402-409
33. Oberfield R, Rossi R (1988) The role of chemotherapy in the treatment of bile duct cancer. World J Surg 12:105-108
34. Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J (1995) Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 221:788- 797
35. Soehendra N,Grimm H (1988) Endoscopie retrograde drainage for bile duct cancer. World J Surg 12:85-90
36. Schlinkert RT, Nagroney DM, van Heerden JA, Adson MA (1992) Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg 5:95
37. Kawarada Y, Mizumoto R (1984) Cholangiocellular carcinoma of the liver. Am J Surg 147:354
38. Chen MF, Jan YY, Wang CS et al. (1989) Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 64:2226-2232
39. Kawarada Y, Mizumoto R (1990) Diagnosis and treatment of Cholangiocellular carcinoma of the liver. Hepatogastroenterology 37:176
40. PichlmayrR,LameschP,Weimann A Tusch G, Ringe B (1995) Surgical treatment of Cholangiocellular carcinoma. World J Surg 19:83-88
41. Holbrook RF, Koo K, Ryan JA (1996) Resection of malignant primary liver tumors. Am J Surg 171:453-455
42. Yamamoto J, Kosuge T, Jakayama T et al. (1992) Surgical treatment of intraheaptic cholangiocarcinoma: four patients surviving mor than five years. Surgery 111:617
43. Ahlgren JD (1993) Neoplasms of the hepatobiliary system. ln:Calbresi P, Schein PS (eds) Medical oncology. MCGraw-Hill, New York, pp713-739
44. Vogt DP (1988) Current management of cholangiocarcinoma. Oncology 2:37-43
45. Goldstein RM, Stone MJ, Tillery GW et al. (1993) Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 166:768-772
46. Yokoyama I, Todo S, Iwatsuki S, Starzl TE (1990) Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37:188
47. Haug CE, Jenkins RL, Rohrer RJ et al. (1992) Liver transplantation for primary hepatic cancer. Transplantation 53:376
48. Senzer NN, Stone MJ, Klintmalm GB, Polter D (1990) Adjuvant radiochemotherapy following orthotopic liver transplantation for bile duct cancer. Transplantation 50:1045-1047
49. Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38:241-256
50. Gazzaniga GM, Filauro M, Bagarolo C et al. (1993) Neoplasm of the hepatkhilum: the role of resection. Hepatogastroenterology 40:244-248
51. Tompkins RK, Saunders K, Roslyn JJ et al. (1990) Changing patterns in diagnosis and management of bile duct cance. Ann Sung 211:614-21
52. Stain SC, Baer HU, Dennison AR et al. (1992) Current management of hilar cholangiocardnoma. Surg Gynecol Obstet 175:579-588
53. Boerma EJ (1990) Research into the results of resection of hilar bile duct cancer. Surgery 108:572-580
54. Pinson CW, Rossi RL (1988) Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg 12:52-9
55. WashburnWK, Lewis WD, Jenkins RL (1995) Aggressive surgical resection forcholangiocarcinoma. Arch Surg 130:270-276
56. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R (1997) What constitutes long term survival after surgery for hilar cholangiocarcinoma. Cancer 79:26-34
57. Muray Lyon IM (1996) Liver tumors. ln:Wetharall DJ, Ledingham JGG, Warrell DA (eds) Oxford Textbook of Surgery (ed 3). Oxford New York Tokyo: Oxford University Press, pp2115-2119
58. Klempnauer J, Ridder GJ.Wasielewski R, Werner M.Weimann A, Pichlmayr R (1997) Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 15:947-954
59. Pitt HA, Gomes AS, Lois JF, Mann LL, et al. (1985) Does preopative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 201:545-553
60. Blumgart LH, Benjamin IS (1994) Cancer of the bile ducts. In: LH B (ed) Surgery of the liver and biliary tract. Second edition. Edinburgh London Madrid: Churchill Livingstone, pp 967-995
61. Ottow RT, August DA, Sugarbaker PH (1985) Treatment of proxima biliary tract carcinoma: an overview of techniques and results. Surgery 97:251-264
62. Bhuiya M, Nimura Y, Kamiya J et al. (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17:653-657
63. Tsuzuki T, Ueda M, Kuramochi S et al. (1990) Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long term survival. Surgery 108:495-501
64. Beckurts KTE, Hblscher AH, Bauer TH, Siewert JR (1997) Maligne Tumoren der Hepaticusgabel: Ergebnisse der chirurgischen Therapie und Prognosefaktoren. Chirurg 68:378-384